397 related articles for article (PubMed ID: 33750339)
1. Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.
Wang Q; Zhao J; Xu Q; Han C; Hou B; Huang Y
BMC Ophthalmol; 2021 Mar; 21(1):129. PubMed ID: 33750339
[TBL] [Abstract][Full Text] [Related]
2. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
4. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
5. Results of office-based fluid-air exchange for postvitrectomy hemorrhage in diabetic retinopathy.
Kim GH; Lee MY
Arq Bras Oftalmol; 2024; 87(2):e20220334. PubMed ID: 38451685
[TBL] [Abstract][Full Text] [Related]
6. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
Sima P; Zoran T
Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
[TBL] [Abstract][Full Text] [Related]
9. [Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy].
Zheng CZ; Ren XJ; Ke YF; Wen DJ; Li XR
Zhonghua Yan Ke Za Zhi; 2021 Jun; 57(6):440-446. PubMed ID: 34098693
[No Abstract] [Full Text] [Related]
10. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
Li X; Jiang Y; Ye C; Li C
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
[TBL] [Abstract][Full Text] [Related]
11. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Sameshima S; Ueda T; Ogata N; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Acta Ophthalmol; 2020 Jun; 98(4):e434-e439. PubMed ID: 31674137
[TBL] [Abstract][Full Text] [Related]
13. Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage. Long-term results and complications.
Han DP; Murphy ML; Mieler WF; Abrams GW
Retina; 1991; 11(3):309-14. PubMed ID: 1961989
[TBL] [Abstract][Full Text] [Related]
14. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
15. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy for proliferative diabetic retinopathy with asteroid hyalosis.
Ikeda T; Sawa H; Koizumi K; Yasuhara T; Kinoshita S; Tano Y
Retina; 1998; 18(5):410-4. PubMed ID: 9801034
[TBL] [Abstract][Full Text] [Related]
17. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach].
Rivas-Aguiño P; García-Amaris RA; Berrocal MH; Sánchez JG; Rivas A; Arévalo JF
Arch Soc Esp Oftalmol; 2009 Jan; 84(1):31-8. PubMed ID: 19173136
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
Pei M; Zhao X; Wan G
Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
Li S; Yang Y; Zou J; Zeng J; Ding C
BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
[TBL] [Abstract][Full Text] [Related]
20. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]